StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BHVN

Biohaven Ltd.

BHVN NYSE Pharmaceutical Preparations EDGAR ↗
$13.37
-0.13 -0.96%

Key statistics

from XBRL data in SEC filings
Market cap
$2.01B
Revenue (TTM)
Net income (TTM)
-$648M
EPS (TTM)
$-5.57
P/E ratio
Dividend yield
Free cash flow
-$610M
Cash
$273M
Total assets
$466M
Gross margin
52-week range
$7.48 – $18.57

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jul 9, 2026 8-K Regulation FD disclosure May 27, 2026 8-K Other events May 5, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 8-K Shareholder vote results May 4, 2026 8-K Results of operations (earnings release) Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Other events Jan 7, 2026 8-K Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure Aug 22, 2025 8-K Other events Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure Jun 4, 2025 8-K Regulation FD disclosure May 15, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Shareholder vote results May 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 28, 2025 8-K Results of operations (earnings release) Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Other events Oct 2, 2024 8-K Regulation FD disclosure; Other events Sep 23, 2024 8-K Other events Aug 16, 2024 8-K Other events Aug 16, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events May 17, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Shareholder vote results May 1, 2024 8-K Other events Apr 22, 2024 8-K Regulation FD disclosure Apr 15, 2024